Microfluidic culture models to study the hydrodynamics of tumor progression and therapeutic response
- 25 April 2013
- journal article
- review article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 110 (8) , 2063-2072
Abstract
The integration of tissue engineering strategies with microfluidic technologies has enabled the design of in vitro microfluidic culture models that better adapt to morphological changes in tissue structure and function over time. These biomimetic microfluidic scaffolds accurately mimic native 3D microenvironments, as well as permit precise and simultaneous control of chemical gradients, hydrodynamic stresses, and cellular niches within the system. The recent application of microfluidic in vitro culture models to cancer research offers enormous potential to aid in the development of improved therapeutic strategies by supporting the investigation of tumor angiogenesis and metastasis under physiologically relevant flow conditions. The intrinsic material properties and fluid mechanics of microfluidic culture models enable high‐throughput anti‐cancer drug screening, permit well‐defined and controllable input parameters to monitor tumor cell response to various hydrodynamic conditions or treatment modalities, as well as provide a platform for elucidating fundamental mechanisms of tumor physiology. This review highlights recent developments and future applications of microfluidic culture models to study tumor progression and therapeutic targeting under conditions of hydrodynamic stress relevant to the complex tumor microenvironment. Biotechnol. Biotechnol. Bioeng. 2013; 110: 2063–2072.Keywords
This publication has 91 references indexed in Scilit:
- Microfluidics for Mammalian Cell ChemotaxisAnnals of Biomedical Engineering, 2011
- Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitroBiomaterials, 2010
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Effect of mechanical factors on the function of engineered human blood microvessels in microfluidic collagen gelsBiomaterials, 2010
- The role of cyclic AMP in normalizing the function of engineered human blood microvessels in microfluidic collagen gelsBiomaterials, 2010
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 2009
- Microfluidics for drug discovery and development: From target selection to product lifecycle managementDrug Discovery Today, 2008
- A perfusable 3D cell–matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transportBiotechnology and Bioengineering, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generationNature Medicine, 2003